No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Cosmos Health Strengthens R&D Leadership and Innovation With the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology
Healthcare and Medical Simulation Market Size Expected to Reach USD 7.04 Bn by 2034
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000
Cosmos Health Offering Stock, Together With Warrants
Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price
Biden Proposes Medicare, Medicaid Coverage of Obesity Drugs